Abnormal erythrocyte population

Abnormal erythrocyte population" is not the name of a specific molecule, receptor, or therapeutic target. Instead, it is an umbrella term used in hematology and clinical laboratory medicine to describe the presence of red blood cells (erythrocytes) that deviate from normal morphology or size within a blood sample. This can include variations in size (anisocytosis), shape (poikilocytosis), or the coexistence of two distinct populations such as microcytic/hypochromic and normocytic/normochromic cells (dimorphic population). These findings are typically observed on peripheral blood smears and are associated with various underlying conditions—most commonly different forms of anemia, myelodysplastic syndromes, nutritional deficiencies, post-transfusion states, and certain therapies like erythropoietin administration. Because "abnormal erythrocyte population" refers to a descriptive finding rather than a discrete molecular entity, it does not have canonical molecular classifications or direct drug interactions. It serves as an important diagnostic clue rather than being itself a therapeutic target. If you require structured information about specific molecules involved in abnormal erythrocyte populations—such as membrane proteins (e.g., spectrin, ankyrin) or enzymes implicated in hereditary anemias—please specify the particular disorder or protein for more targeted data.

Other names

Abnormal red blood cell populationDimorphic red blood cell populationAnisocytosis (when referring to size variation)Poikilocytosis (when referring to shape variation)